Lysogene

Lysogene is a gene therapy company focused on orphan diseases of the central nervous system.

After a failed phase 2/3 study, Lysogene has suspended trading of its shares and is seeking partnerships and investors to try and stay afloat.

Gabrielle Masson Dec 7, 2022 11:15am